论文部分内容阅读
目的 探讨加替沙星的不同给药方案治疗相同疾病的经济效果。方法 采用药物经济学的成本-效果分析法,对治疗慢性支气管炎急性发作的加替沙星 3 种用药方案进行评价。结果 3 种用药(A、B、C)方案在疗效比较上无显著性差异;药物成本分别为80.36元、187.60元、1 033.02元,成本效果比分别为0.87、2.05、10.87。结论 从药物经济学分析,A组方案成本最小,最为安全、有效、经济。
Objective To investigate the economic effects of different dosage regimens of gatifloxacin on the same diseases. Methods Cost-effectiveness analysis was used to evaluate the three dosage regimens of gatifloxacin in the treatment of acute exacerbation of chronic bronchitis. Results There was no significant difference in efficacy between the three drugs (A, B and C). The cost of drugs was 80.36 yuan, 187.60 yuan and 1.033.02 yuan respectively, and the cost-effectiveness ratios were 0.87, 2.05 and 10.87 respectively. Conclusion From the perspective of pharmacoeconomics, group A has the lowest cost and the safest, most effective and economic method.